Crystalline Hydrochloride Salts of N-Ethyl-2-(5-Fluoro-1h-Indol-3-Yl)-N-Methylethan-1-Amine
Copyright © Targeted News Service 2024
2024-12-03
ALEXANDRIA, Virginia, Dec. 3 -- GILGAMESH PHARMACEUTICALS, INC., New York, New York has been assigned a patent (No. US 12157722 B1, initially filed Sept. 14, 2023) developed by four inventors Andrew Carry Kruegel, Millington, New Jersey; William Leong, Westfield, New Jersey; Yameng He, Halifax, Canada; and Lauren MacEachern, Halifax, Canada, for "Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine." . . .